The finding that the IC50 of NB73 in myeloma cells that harbor low amounts of FOXM1 (MM1.S and XG-7) was approximately 2-fold higher than that in OPM2 and Delta47 cells (Fig. S7) supports the contention that the inhibitor exhibits specificity. Here, FOXM1 is linked to plasma cell myeloma.